Skip to main content

Advertisement

SpringerLink
Log in

Bilateral retinoblastoma: clinical presentation, management and treatment

  • Case Report
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Management of retinoblastoma (Rb), the most common intraocular malignant tumor in childhood, is tailored to each individual case and based on the overall situation. We present a case of bilateral Rbs in a 4-month-old girl, referred to our center for bilateral leukocoria. In the right eye, the optic disc was partially visible, and three large foci of retinoblastoma were noted adjective in the vitreous cavity with satellite retinal detachment. The macula was obscured by the tumors. The tumor was therefore classified as group D (International classification of retinoblastoma), and thus underwent intravenous chemotherapy with the standard three-agent protocol of ifosfamide, carboplatin and etoposide (ICE protocol) delivered monthly for six cycles, regressing with a type I calcified pattern. The left eye presented three multifocal yellow-white retinal masses, with a total retinal detachment, and secondary glaucoma. The lesions were classified as group E and, therefore, taking the results obtained by Shields et al. in group E tumors into consideration, underwent enucleation. This case clearly shows that this cancer is curable if detected at a stage in which it is still contained within the retina, subretinal space or vitreous, and that the management of Rb relies on an experienced team of ocular oncologists, pediatricians and pediatric ophthalmologists working together for the single goal of saving the child’s life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Shields CL, Shields JA (2006) Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17:228–234

    Article  PubMed  Google Scholar 

  2. Shields JA, Shields CL (2008) Retinoblastoma. In: Shields JA, Shields CL (eds) Atlas of Intraocular Tumors. Lipincott Williams Wilkins, Philadelphia, pp 293–365

    Google Scholar 

  3. Shields JA, Shields CL (1992) Management and prognosis of retinoblastoma. Intraocular tumors: a text and atlas. WB Saunders, Philadelphia, pp 377–392

    Google Scholar 

  4. Epstein J, Shields CL, Shields JA (2003) Trends in the management of retinoblastoma; Evaluation of 1,196 consecutive eyes during 1974–2001. J Pediatr Ophthalmol Strab 40:196–203

    Google Scholar 

  5. Shields CL, Meadows AT, Leahey AM, Shields JA (2004) Continuing challenges in the management of retinoblastoma with chemoreduction. Retina 24:849–862

    Article  PubMed  Google Scholar 

  6. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ (2002) Factors predictive of recurrence of retinal tumor, vitreous seeds and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 120:460–464

    Article  PubMed  Google Scholar 

  7. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh AD, Friedman D, Naduvilaths TJ (2002) Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 133:657–664

    Article  PubMed  Google Scholar 

  8. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA (2004) Chemoreduction for retinoblastoma analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol 138:329–337

    Article  PubMed  Google Scholar 

  9. Murphree AL (2005) Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18(1):41–53

    Article  Google Scholar 

  10. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA (2006) The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276–2280

    Article  PubMed  Google Scholar 

  11. Zigiotti GL, Cavarretta S, Morara M, Nam SM, Ranno S, Pichi F, Lembo A, Lupo S, Nucci P, Meduri A (2012) Standard enucleation with aluminium oxide implant (bioceramic) covered with patient’s sclera. Sci World J 2012:481584. doi:10.1100/2012/481584

    Article  Google Scholar 

  12. Karcioglu ZA, Hadjistilianou T (2004) Ocular tumors. In: Karcioglu ZA (ed) Orbital tumors—diagnosis and treatment. Springer, New York, pp 257–265

    Google Scholar 

  13. Knudson AG Jr (1974) Heredity and human cancer. Am J Pathol 77(1):77–84

    PubMed  Google Scholar 

  14. DePotter P, Shields CL, Shields JA (1994) Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus 31:26–31

    CAS  Google Scholar 

  15. Shields CL, Meadows AT, Shields JA et al (2001) Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 119:1269–1272

    Article  PubMed  CAS  Google Scholar 

  16. Moll AC, Imhof SM, Schouten-Van Meeteren AY et al (2003) Chemoreduction for retinoblastoma. Arch Ophthalmol 121:1513

    PubMed  Google Scholar 

  17. Uusitalo MS, Van Quill KR, Scott IU et al (2001) Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 119:41–48

    Article  PubMed  CAS  Google Scholar 

  18. Honavar SG, Singh AD, Shields CL et al (2002) Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 120:923–931

    Article  PubMed  Google Scholar 

  19. Eagle RC Jr (2009) High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med 133:1203–1209

    PubMed  Google Scholar 

  20. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN (1996) Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114:1339–1343

    Article  PubMed  CAS  Google Scholar 

  21. Gallie BL, Budning A, DeBoer G et al (1996) Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 114:1321–1328

    Article  PubMed  CAS  Google Scholar 

  22. Murphree AL, Villablanca JG, Deegan WF III et al (1996) Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114:1348–1356

    Article  PubMed  CAS  Google Scholar 

  23. Shields CL, De Potter P, Himelstein BP et al (1996) Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114:1330–1338

    Article  PubMed  CAS  Google Scholar 

  24. Shields CL, Shields JA (2002) Chemotherapy for retinoblastoma. Editor Med Ped Oncol 38:377–378

    Article  Google Scholar 

  25. Shields CL, Shields JA (2004) Changing management of retinoblastoma. Clin Expiment Ophthalmol 32:345–346

    Article  Google Scholar 

  26. Shields JA, Shields CL, Meadows AT (2005) Chemoreduction in the management of retinoblastoma. Am J Ophthalmol 140:505–506

    Article  PubMed  Google Scholar 

  27. Antoneli CB, Ribeiro KB, Rodriguez-Galindo C et al (2007) The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J Pediatr Hematol Oncol 29(10):700–704

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. San Giuseppe Hospital, University Eye Clinic, Via San Vittore 12, 20123, Milan, Italy

    Francesco Pichi, Andrea Lembo & Paolo Nucci

  2. Department of Ophthalmology, Azienda Ospedaliera e Universitaria Santa Maria alle Scotte, Siena, Italy

    Mariacarla De Luca & Theodora Hadjistilianou

Authors
  1. Francesco Pichi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea Lembo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mariacarla De Luca
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Theodora Hadjistilianou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Nucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Pichi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pichi, F., Lembo, A., De Luca, M. et al. Bilateral retinoblastoma: clinical presentation, management and treatment. Int Ophthalmol 33, 589–593 (2013). https://doi.org/10.1007/s10792-012-9703-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-012-9703-5

Keywords

Search

Navigation